103 related articles for article (PubMed ID: 6664224)
1. Agonist and antagonist properties of some benzomorphans on nociceptive reaction and intestinal transit in rats.
Gambino MC; Petrillo P; Tavani A
Life Sci; 1983; 33 Suppl 1():461-4. PubMed ID: 6664224
[TBL] [Abstract][Full Text] [Related]
2. Bremazocine induces antinociception, but prevents opioid-induced constipation and catatonia in rats and precipitates withdrawal in morphine-dependent rats.
Petrillo P; Gambino MC; Tavani A
Life Sci; 1984 Aug; 35(9):917-27. PubMed ID: 6381949
[TBL] [Abstract][Full Text] [Related]
3. Unexpected antagonism in the rat vas deferens by benzomorphans which are agonists in other pharmacological tests.
Gillan MG; Kosterlitz HW; Magnan J
Br J Pharmacol; 1981 Jan; 72(1):13-5. PubMed ID: 6261863
[TBL] [Abstract][Full Text] [Related]
4. Opiate receptor interactions of benzomorphans in rat brain homogenates.
Pert CB; Snyder SH; May EL
J Pharmacol Exp Ther; 1976 Feb; 196(2):316-22. PubMed ID: 1255479
[TBL] [Abstract][Full Text] [Related]
5. Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey.
Hutchinson M; Kosterlitz HW; Leslie FM; Waterfield AA
Br J Pharmacol; 1975 Dec; 55(4):541-6. PubMed ID: 2359
[TBL] [Abstract][Full Text] [Related]
6. Mr 2033 CL--a novel non-morphine-like opioid analgesic.
Stockhaus K; Ensinger HA; Gaida W; Jennewein HM; Merz H
NIDA Res Monogr; 1983 Apr; 43():144-9. PubMed ID: 6135993
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of a new opioid agonist on reproductive endocrine activity in rats of both sexes.
Markó M; Römer D
Life Sci; 1983 Jul; 33(3):233-40. PubMed ID: 6865656
[TBL] [Abstract][Full Text] [Related]
8. Stereospecific opiate receptors in the actions of thyrotropin releasing hormone and morphine on gastrointestinal transit.
Bhargava HN; Pillai NP
Life Sci; 1985 Jan; 36(1):83-8. PubMed ID: 2981381
[TBL] [Abstract][Full Text] [Related]
9. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
[TBL] [Abstract][Full Text] [Related]
10. Interaction of U-69,593 with mu-, alpha- and kappa-opioid binding sites and its analgesic and intestinal effects in rats.
La Regina A; Petrillo P; Sbacchi M; Tavani A
Life Sci; 1988; 42(3):293-301. PubMed ID: 2826959
[TBL] [Abstract][Full Text] [Related]
11. Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity.
Bianchi G; Fiocchi R; Tavani A; Manara L
Life Sci; 1982 May; 30(22):1875-83. PubMed ID: 7109826
[TBL] [Abstract][Full Text] [Related]
12. Bremazocine: a potent, long-acting opiate kappa-agonist.
Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM
Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759
[No Abstract] [Full Text] [Related]
13. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates.
Ko MC; Husbands SM
J Pharmacol Exp Ther; 2009 Jan; 328(1):193-200. PubMed ID: 18842704
[TBL] [Abstract][Full Text] [Related]
14. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the respiratory depressant and analgesic effects of bremazocine, a kappa-agonist.
Pazos A; Tristán C; Flórez J
Life Sci; 1983; 33 Suppl 1():579-81. PubMed ID: 6319913
[TBL] [Abstract][Full Text] [Related]
16. N-tetrahydrofurfuryl benzomorphans: comparison of a kappa and an agonist/antagonist analgesic.
Wood PL
Neuropeptides; 1985 Feb; 5(4-6):323-6. PubMed ID: 2987733
[TBL] [Abstract][Full Text] [Related]
17. The influence of the kappa-agonist bremazocine on ingestive behaviour in mice and rats.
Hartig U; Opitz K
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):4-12. PubMed ID: 6307194
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.
Manara L; Bianchi G; Ferretti P; Tavani A
J Pharmacol Exp Ther; 1986 Jun; 237(3):945-9. PubMed ID: 3012075
[TBL] [Abstract][Full Text] [Related]
19. Bremazocine-induced urination in rats of different sizes.
Leander JD
Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):141-4. PubMed ID: 3671877
[TBL] [Abstract][Full Text] [Related]
20. The effects of morphine and nalbuphine on intestinal transit in mice.
Wong CL
Methods Find Exp Clin Pharmacol; 1984 Nov; 6(11):685-9. PubMed ID: 6530907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
